Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Rokas Navickas
Lithuania is one of the high CVD risk regions in Europe. The mortality due to CVD is 2.5 times higher in comparison to western countries and accounts for 23 thousand deaths every year.An adequate and timely prevention is needed in order to reduce CVD mortality and morbidity.
In 2005 a Cardiovascular Disease Prevention Program was launched immediately after approval of the Lithuanian Health Ministry. The main aim of the Program was to reduce the incidence of CVD (myocardial infarction, unstable angina and stroke), its targets were asymptomatic patients having diabetes mellitus and atherosclerosis.The general practitioner would perform the initial screening. It includes their risk assessment (cholesterol, glucose, arterial blood pressure assessment, weight, physical activity and smoking) and an individualised prevention plan. Patients having a high CVD risk would be referred to specialised cardiovascular disease prevention units.The Prevention Program involves male aged 40 to 55 and female aged 50 to 65 with no previously diagnosed CVD. These are people with a known or suspected diabetes mellitus, metabolic syndrome corresponding to 3 or more of the following criteria:
All participants undergo a baseline assessment, which includes their medical history, CVD risk profile and lifestyle assessment, evaluation of cardiovascular (CV) family history and physical examination.Subsequently further investigations are carried out to asses the cardiovascular system:
The Program is carried out by cardiologist who after the assessment of the patient and the performed investigations shape an individualised risk factor adjustment and treatment plan:
High CVD risk patients are followed up at the CV Prevention Centre every 1-2 years.
For more information, please contact:
Rimvydas Slapikas (email)National CVD Prevention Coordinator in Lithuania
© 2017 European Society of Cardiology. All rights reserved